Spotlight
Specialty
Partners
CME/CE
Precision Medicine: A Collaborative and Multidisciplinary Approach to Identifying Biomarkers : Episode 1
Targetable Mutations and Rearrangements in Lung Cancers
Expert participants share their perspective on the advent of precision medicine in lung cancer, following the discovery of several key driver mutations and alterations.
Now Viewing
EP: 1.Targetable Mutations and Rearrangements in Lung Cancers
EP: 2.Targetable Mutations Found in Breast Cancers
EP: 3.Addressing Barriers to Adequate Biomarker Testing in Cancer Care
EP: 4.Optimizing Cancer Care: Interpreting and Communicating Biomarker Testing Results
EP: 5.Armamentarium of Biomarker Testing Strategies in Cancer Care
EP: 6.Updating Biomarker Testing Strategies as Cancer Care Evolves
EP: 7.Optimizing the Timing and Utilization of Biomarker Testing in Cancer Care
EP: 8.Improving Uptake of Biomarker Testing and Precision Medicine in Cancer Care
EP: 9.The Value of Molecular Tumor Boards and Multidisciplinary Care
EP: 10.Role of a Pharmacist in the Multidisciplinary Approach to Identifying Biomarkers
EP: 11.Role of a Pharmacist in Developing Treatment Pathways and Educating Patients
EP: 12.Future Directions in Precision Medicine: An Evolving Treatment Landscape
Related Videos
Related Content
